Alzheimer’s disease risk gene Wwox controls amyloid pathology through metabolic reprogramming

Clicks: 2
ID: 331948
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #160 of 162 articles by views in Brain communications

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 162 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Genome-wide association studies have identified multiple loci that contribute to late-onset Alzheimer’s disease risk, yet the functional mechanisms of many candidate genes remain unclear. WW-domain containing oxidoreductase (WWOX) is one such gene associated with disease and downregulated in patient brains, but its role in neurodegeneration is poorly understood. Here, we use Drosophila models to investigate the cell-type-specific and mechanistic roles of Wwox in ageing and amyloid-β42 (Aβ42)-induced pathology. Neuronal and glial knockdown of Wwox reduced lifespan and increased sleep drive, indicating a role in brain homeostasis. In an Aβ42 transgenic model, neuronal Wwox knockdown exacerbated toxicity, shortening lifespan, impairing locomotion, and increasing soluble Aβ42 levels. Transcriptomic and metabolomic analyses revealed that Wwox knockdown in an Aβ42 transgenic model promotes metabolic reprogramming, characterised by elevated lactate dehydrogenase (Ldh) expression and increased lactate levels, driven by activation of the stress-responsive transcription factor Atf4. Genetic reduction of Ldh rescued locomotor deficits, identifying dysregulated pyruvate metabolism as a key mediator of Wwox-dependent neurotoxicity. Conversely, overexpression of Wwox in neurons markedly reduced amyloid burden, improved survival and locomotor function, and reversed Aβ42-induced transcriptional changes. Both Aβ42 and the protective effects of Wwox were associated with altered amino acid metabolism, including changes in the cysteine and L-methionine pathway. Together, these findings identify WWOX as a regulator of neuronal metabolic state, linking genetic risk to amyloid pathology via metabolic reprogramming, and highlight WWOX activation as a potential therapeutic strategy in Alzheimer’s disease.
Reference Key
openalex_W7221081647 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hannah Clarke, Daniel C. Maddison, Leonardo Amadio, Edgar Buhl, Clément Regnault, Owen M. Peters, James J. L. Hodge, Gaynor Ann Smith
Journal Brain communications
Year 2026
DOI
10.1093/braincomms/fcag385
URL
https://doi.org/10.1093/braincomms/fcag385
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.